Bladder cancer exhibits significant sex-based disparities, with men showing higher incidence rates and women experiencing more aggressive disease and poorer survival outcomes.
This study investigates sex-specific somatic genetic alterations (GAs) in urothelial bladder cancer and their effects on survival, immune cell infiltration, and immune checkpoint inhibitor (ICI) responses.
